Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer

FEBS Letters

Volumn 588, Issue 17, 2014, Pages 3170-3179

  Inoguchi, Satoru ^a   Seki, Naohiko ^b   Chiyomaru, Takeshi ^a   Ishihara, Tomoaki ^a   Matsushita, Ryosuke ^a   Mataki, Hiroko ^a   Itesako, Toshihiko ^a   Tatarano, Shuichi ^a   Yoshino, Hirofumi ^a   Goto, Yusuke ^b   Nishikawa, Rika ^b   Nakagawa, Masayuki ^a   Enokida, Hideki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Forkhead box protein M1; microRNA; microRNA 24 1; Tumour suppressor

Indexed keywords

FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; MICRORNA; MICRORNA 24 1; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; FOXM1 GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLADDER CANCER; FORKHEAD BOX PROTEIN M1; MICRORNA; MICRORNA-24-1; TUMOUR SUPPRESSOR;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 84906264610     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.06.058     Document Type: Article

References (38)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J. Clin. 62 2012 10 29
2. T.C. Zuiverloon, A.J. Nieuweboer, H. Vekony, W.J. Kirkels, C.H. Bangma, and E.C. Zwarthoff Markers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review Eur. Urol. 61 2012 128 145
3. C. Luke, E. Tracey, A. Stapleton, and D. Roder Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control Intern. Med. J. 40 2010 357 362
4. J. Bellmunt, and D.P. Petrylak New therapeutic challenges in advanced bladder cancer Semin. Oncol. 39 2012 598 607
5. M. De Santis et al. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986 J. Clin. Oncol. 30 2012 191 199
6. R.W. Carthew, and E.J. Sontheimer Origins and mechanisms of miRNAs and siRNAs Cell 136 2009 642 655
7. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
8. W. Filipowicz, S.N. Bhattacharyya, and N. Sonenberg Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9 2008 102 114
9. J.M. Friedman, and P.A. Jones MicroRNAs: critical mediators of differentiation, development and disease Swiss Med. Wkly. 139 2009 466 472
10. O. Hobert Gene regulation by transcription factors and microRNAs Science 319 2008 1785 1786
11. M.V. Iorio, and C.M. Croce MicroRNAs in cancer: small molecules with a huge impact J. Clin. Oncol. 27 2009 5848 5856
12. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
13. Y. Guo, W. Fu, H. Chen, C. Shang, and M. Zhong MiR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein Oncol. Rep. 27 2012 1097 1103
14. P.J. Mishra et al. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism PLoS ONE 4 2009 e8445
15. J. Szczyrba et al. Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma Int. J. Cancer 132 2013 775 784
16. W.W. Du et al. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling J. Cell Sci. 126 2013 1440 1453
17. S.C. Lin, C.J. Liu, J.A. Lin, W.F. Chiang, P.S. Hung, and K.W. Chang MiR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis Oral Oncol. 46 2010 204 208
18. X. Liu et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma FEBS Lett. 584 2010 4115 4120
19. W. Qin, Y. Shi, B. Zhao, C. Yao, L. Jin, J. Ma, and Y. Jin MiR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells PLoS ONE 5 2010 e9429
20. F. Zhao, and E.W. Lam Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance Front. Med. 6 2012 376 380
21. Sobin, L.H., Gospodarowicz, M.K., and Wittekind, C. (2009) TNM classification of malignant tumours, 7th ed. International Union Against Cancer (UICC). New York: Wiley-Blackwell, pp. 262-265.
22. M. Takemoto et al. Metanestin, a glycoprotein with metastasis-associated expression in transitional cell carcinoma of the urinary bladder Int. J. Cancer 74 1997 7 14
23. T. Ichimi et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer Int. J. Cancer 125 2009 345 352
24. H. Yoshino et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer Br. J. Cancer 104 2011 808 818
25. K. Kawakami et al. The functional significance of miR-1 and miR-133a in renal cell carcinoma Eur. J. Cancer 48 2012 827 836
26. Y. Goto et al. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer FEBS Lett. 10 2014 1973 1982
27. H. Hidaka et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma Oncotarget 3 2012 44 57
28. T. Itesako et al. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster PLoS ONE 9 2014 e84311
29. T. Kinoshita et al. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma Br. J. Cancer 109 2013 2636 2645
30. L. Chen et al. MiR-24 regulates the proliferation and invasion of glioma by ST7L via beta-catenin/Tcf-4 signaling Cancer Lett. 329 2013 174 180
31. M. Halasi, and A.L. Gartel FOX(M1) news - it is cancer Mol. Cancer Ther. 12 2013 245 254
32. P. Raychaudhuri, and H.J. Park FoxM1: a master regulator of tumor metastasis Cancer Res. 71 2011 4329 4333
33. I.C. Wang et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase Mol. Cell. Biol. 25 2005 10875 10894
34. K. Kawakami, H. Enokida, T. Tachiwada, K. Nishiyama, N. Seki, and M. Nakagawa Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma J. Urol. 178 2007 301 307
35. A.L. Gartel A new target for proteasome inhibitors: FoxM1 Expert Opin. Investig. Drugs 19 2010 235 242
36. K. Athanasoula, H. Gogas, K. Polonifi, A.G. Vaiopoulos, A. Polyzos, and M. Mantzourani Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials Cancer Lett. 347 2014 175 182
37. S. Nakamura et al. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia Carcinogenesis 31 2010 2012 2021
38. Z. Wang et al. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma Mol. Cancer Ther. 12 2013 759 767